DeepMed Research

CDC ENTEBBE

🇺🇬Uganda

Country: 🇺🇬Uganda

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

TBTC NAA Study: Pilot Study of Surrogate Markers for Outcome of TB Treatment

Completed

Conditions: Tuberculosis

First Posted Date: 2001-09-10

Last Posted Date: 2011-08-03

Lead Sponsor: Centers for Disease Control and Prevention

Target Recruit Count: 300

Registration Number: NCT00023439

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States
🇺🇬
Makerere University Medical School, Kampala, Uganda
🇺🇸
Denver Department of Public Health and Hospitals, Denver, Colorado, United States

and more 11 locations

TBTC Study 23C: Pharmacokinetics of Intermittent Rifabutin and Isoniazid With Daily Efavirenz

Phase 2

Completed

Conditions: HIV Infections
Tuberculosis

First Posted Date: 2001-09-10

Last Posted Date: 2012-06-05

Lead Sponsor: Centers for Disease Control and Prevention

Target Recruit Count: 20

Registration Number: NCT00023413

Locations: 🇺🇸
Chicago VA Medical Center (Lakeside), Chicago, Illinois, United States
🇺🇸
Johns Hopkins University School of Medicine, Baltimore, Maryland, United States
🇺🇸
Duke University Medical Center, Durham, North Carolina, United States

and more 20 locations

TBTC Study 25: Study of the Tolerability of Higher Doses of Rifapentine in the Treatment of Tuberculosis

Phase 2

Completed

Conditions: Tuberculosis

First Posted Date: 2001-09-10

Last Posted Date: 2005-09-13

Lead Sponsor: Centers for Disease Control and Prevention

Target Recruit Count: 150

Registration Number: NCT00023426

Locations: 🇺🇸
Thomas Street Clinic, Houston, Texas, United States
🇺🇸
New York University School of Medicine, New York, New York, United States
🇺🇸
University of California, San Francisco, San Francisco, California, United States

and more 20 locations

TBTC Study 23A: Pharmacokinetics of Intermittent Isoniazid and Rifabutin in HIV-TB

Phase 2

Completed

Conditions: HIV Infections
Tuberculosis

First Posted Date: 2001-09-10

Last Posted Date: 2005-09-13

Lead Sponsor: Centers for Disease Control and Prevention

Target Recruit Count: 150

Registration Number: NCT00023348

Locations: 🇺🇸
Denver Department of Public Health and Hospitals, Denver, Colorado, United States
🇺🇸
Hines VA Medical Center, Hines, Illinois, United States
🇨🇦
University of Manitoba, Winnipeg, Manitoba, Canada

and more 20 locations

TBTC Study 25PK: Intensive Pharmacokinetic Study of Three Doses of Rifapentine and 25-Desacetyl Rifapentine

Not Applicable

Completed

Conditions: Tuberculosis

First Posted Date: 2001-09-10

Last Posted Date: 2005-09-13

Lead Sponsor: Centers for Disease Control and Prevention

Target Recruit Count: 36

Registration Number: NCT00023387

Locations: 🇺🇸
LA County/USC Medical Center, Los Angeles, California, United States
🇺🇸
Chicago VA Medical Center (Lakeside), Chicago, Illinois, United States
🇺🇸
Johns Hopkins University School of Medicine, Baltimore, Maryland, United States

and more 20 locations

TBTC Study 22: Efficacy of Once-Weekly Rifapentine and Isoniazid in Treatment of Tuberculosis

Phase 3

Completed

Conditions: Pulmonary Tuberculosis

First Posted Date: 2001-09-10

Last Posted Date: 2005-09-05

Lead Sponsor: Centers for Disease Control and Prevention

Target Recruit Count: 1000

Registration Number: NCT00023335

Locations: 🇺🇸
LA County/USC Medical Center, Los Angeles, California, United States
🇺🇸
University of California, San Francisco, San Francisco, California, United States
🇺🇸
Chicago VA Medical Center (Lakeside), Chicago, Illinois, United States

and more 20 locations

TBTC Study 23B:Intensive PK of the Nelfinavir Rifabutin Interaction in Patients With HIV-TB

Phase 4

Completed

Conditions: HIV Infections
Tuberculosis

First Posted Date: 2001-09-10

Last Posted Date: 2005-09-05

Lead Sponsor: Centers for Disease Control and Prevention

Target Recruit Count: 20

Registration Number: NCT00023400

Locations: 🇨🇦
University of British Columbia, Vancouver, British Columbia, Canada
🇺🇸
LA County/USC Medical Center, Los Angeles, California, United States
🇺🇸
Johns Hopkins University School of Medicine, Baltimore, Maryland, United States

and more 20 locations

TBTC Study 23: Treatment of HIV-Related Tuberculosis Using a Rifabutin-Based Regimen

Not Applicable

Completed

Conditions: HIV Infections
Tuberculosis

First Posted Date: 2001-09-10

Last Posted Date: 2005-09-05

Lead Sponsor: Centers for Disease Control and Prevention

Target Recruit Count: 215

Registration Number: NCT00023361

Locations: 🇺🇸
Seattle King County Health Department, Seattle, Washington, United States
🇺🇸
LA County/USC Medical Center, Los Angeles, California, United States
🇺🇸
University of California, San Francisco, San Francisco, California, United States

and more 20 locations

TBTC Study 24: Intermittent Treatment of TB With Isoniazid Resistance or Intolerance

Not Applicable

Completed

Conditions: Tuberculosis

Interventions: Drug: Rifampin
Drug: Pyrazinamide
Drug: Ethambutol
Drug: REZ

First Posted Date: 2001-09-10

Last Posted Date: 2011-08-03

Lead Sponsor: Centers for Disease Control and Prevention

Target Recruit Count: 98

Registration Number: NCT00023374

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States
🇨🇦
University of British Columbia, Vancouver, British Columbia, Canada
🇺🇸
Washington, D.C. VAMC, Washington, District of Columbia, United States

and more 20 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy